Extracorporeal photopheresis promotes IL-1β production

Journal of Immunology

Volumn 194, Issue 6, 2015, Pages 2569-2577

  Yakut, Erhan ^a   Jakobs, Christopher ^b   Peric, Adriana ^a   Michel, Gabriela ^a   Baal, Nelli ^a   Bein, Gregor ^a   Brune, Bernhard ^c   Hornung, Veit ^a   Hackstein, Holger ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; ADENOSINE TRIPHOSPHATE; CD14 ANTIGEN; LIPOPOLYSACCHARIDE; METHOXSALEN; PHOTOSENSITIZING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; EXTRACORPOREAL PHOTOPHERESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; LEUKAPHERESIS; MONOCYTE; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CELL CULTURE; CELL SURVIVAL; DENDRITIC CELL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; KNOCKOUT MOUSE; METABOLISM; MONONUCLEAR CELL; PROCEDURES; PUVA; RADIATION RESPONSE; ULTRAVIOLET RADIATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD14; CASPASE 1; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; METHOXSALEN; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; PHOTOPHERESIS; PHOTOSENSITIZING AGENTS; ULTRAVIOLET RAYS;

EID: 84924530043     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400694     Document Type: Article

References (52)

1. Greinix, H. T., B. Volc-Platzer, P. Kalhs, G. Fischer, A. Rosenmayr, F. Keil, H. Hönigsmann, and R. M. Knobler. 2000. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood 96: 2426-2431.
2. Flowers, M. E., J. F. Apperley, K. van Besien, A. Elmaagacli, A. Grigg, V. Reddy, A. Bacigalupo, H. J. Kolb, L. Bouzas, M. Michallet, et al. 2008. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 112: 2667-2674.
3. Hackstein, H., J. Misterek, A. Nockher, A. Reiter, G. Bein, and W. Woessmann. 2009. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications. Transfusion 49: 2366-2373.
4. Marques, M. B., and J. Schwartz. 2011. Update on extracorporeal photopheresis in heart and lung transplantation. J. Clin. Apher. 26: 146-151.
5. Edelson, R., C. Berger, F. Gasparro, B. Jegasothy, P. Heald, B. Wintroub, E. Vonderheid, R. Knobler, K. Wolff, G. Plewig, et al. 1987. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N. Engl. J. Med. 316: 297-303.
6. Knobler, R., M. Duvic, C. Querfeld, D. Straus, S. Horwitz, J. Zain, F. Foss, T. Kuzel, K. Campbell, and L. Geskin. 2012. Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis. Photodermatol. Photoimmunol. Photomed. 28: 250-257.
7. Quaglino, P., R. Knobler, M. T. Fierro, P. Savoia, E. Marra, P. Fava, and M. G. Bernengo. 2013. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature. Int. J. Dermatol. 52: 1308-1318.
8. Garban, F., S. Carras, P. Drillat, M. C. Jacob, B. Fabre, M. Callanan, S. Courby, C. Makowski, J. Y. Cahn, and R. Gressin. 2012. Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemia. Ann. Oncol. 23: 2386-2390.
9. Trautinger, F., U. Just, and R. Knobler. 2013. Photopheresis (extracorporeal photochemotherapy). Photochem. Photobiol. Sci. 12: 22-28.
10. Maeda, A., A. Schwarz, A. Bullinger, A. Morita, D. Peritt, and T. Schwarz. 2008. Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells. J. Immunol. 181: 5956-5962.
11. Gatza, E., C. E. Rogers, S. G. Clouthier, K. P. Lowler, I. Tawara, C. Liu, P. Reddy, and J. L. M. Ferrara. 2008. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 112: 1515-1521.
12. Capitini, C. M., J. P. E. Davis, S. M. Larabee, S. Herby, N. M. Nasholm, and T. J. Fry. 2011. Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination. Biol. Blood Marrow Transplant. 17: 790-799.
13. Berger, C., K. Hoffmann, J. G. Vasquez, S. Mane, J. Lewis, R. Filler, A. Lin, H. Zhao, T. Durazzo, A. Baird, et al. 2010. Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy. Blood 116: 4838-4847.
14. Shiue, L. H., A. M. Alousi, C. Wei, C. M. Hosing, M. Duvic, and X. Ni. 2013. Augmentation of blood dendritic cells by extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma and graft-versus-host disease. J. Invest. Dermatol. 133: 2098-2100.
15. Vowels, B. R., M. Cassin, M. H. Boufal, L. J. Walsh, and A. H. Rook. 1992. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J. Invest. Dermatol. 98: 686-692.
16. Dinarello, C. A. 2011. A clinical perspective of IL-1b as the gatekeeper of inflammation. Eur. J. Immunol. 41: 1203-1217.
17. Duewell, P., H. Kono, K. J. Rayner, C. M. Sirois, G. Vladimer, F. G. Bauernfeind, G. S. Abela, L. Franchi, G. Nuñez, M. Schnurr, et al. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361.
18. Hornung, V., A. Ablasser, M. Charrel-Dennis, F. Bauernfeind, G. Horvath, D. R. Caffrey, E. Latz, and K. A. Fitzgerald. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458: 514-518.
19. Bauernfeind, F., and V. Hornung. 2013. Of inflammasomes and pathogens-sensing of microbes by the inflammasome. EMBO Mol. Med. 5: 814-826.
20. Guma, M., L. Ronacher, R. Liu-Bryan, S. Takai, M. Karin, and M. Corr. 2009. Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum. 60: 3642-3650.
21. Stehlik, C. 2009. Multiple interleukin-1beta-converting enzymes contribute to inflammatory arthritis. Arthritis Rheum. 60: 3524-3530.
22. Joosten, L. A. B., M. G. Netea, G. Fantuzzi, M. I. Koenders, M. M. A. Helsen, H. Sparrer, C. T. Pham, J. W. M. van der Meer, C. A. Dinarello, and W. B. van den Berg. 2009. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum. 60: 3651-3662.
23. Mayer-Barber, K. D., D. L. Barber, K. Shenderov, S. D. White, M. S. Wilson, A. Cheever, D. Kugler, S. Hieny, P. Caspar, G. Núñez, et al. 2010. Caspase-1 independent IL-1beta production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184: 3326-3330.
24. Shenderov, K., N. Riteau, R. Yip, K. D. Mayer-Barber, S. Oland, S. Hieny, P. Fitzgerald, A. Oberst, C. P. Dillon, D. R. Green, et al. 2014. Cutting edge: endoplasmic reticulum stress licenses macrophages to produce mature IL-1b in response to TLR4 stimulation through a caspase-8-and TRIF-dependent pathway. J. Immunol. 192: 2029-2033.
25. Gurung, P., P. K. Anand, R. K. Malireddi, L. Vande Walle, N. Van Opdenbosch, C. P. Dillon, R. Weinlich, D. R. Green, M. Lamkanfi, and T. D. Kanneganti. 2014. FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J. Immunol. 192: 1835-1846.
26. Dinarello, C. A., A. Simon, and J. W. M. van der Meer. 2012. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 11: 633-652.
27. Baxevanis, C. N., G. V. Dedoussis, A. D. Gritzapis, G. P. Stathopoulos, and M. Papamichail. 1994. Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors. Br. J. Cancer 70: 625-630.
28. O'Sullivan, B. J., H. E. Thomas, S. Pai, P. Santamaria, Y. Iwakura, R. J. Steptoe, T. W. H. Kay, and R. Thomas. 2006. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J. Immunol. 176: 7278-7287.
29. Ghiringhelli, F., L. Apetoh, A. Tesniere, L. Aymeric, Y. Ma, C. Ortiz, K. Vermaelen, T. Panaretakis, G. Mignot, E. Ullrich, et al. 2009. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 15: 1170-1178.
30. Hackstein, H., T. Taner, A. F. Zahorchak, A. E. Morelli, A. J. Logar, A. Gessner, and A. W. Thomson. 2003. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101: 4457-4463.
31. Jakobs, C., E. Bartok, A. Kubarenko, F. Bauernfeind, and V. Hornung. 2013. Immunoblotting for active caspase-1. Methods Mol. Biol. 1040: 103-115.
32. Dzionek, A., A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, S. Miltenyi, D.W. Buck, and J. Schmitz. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165: 6037-6046.
33. Schütz, F., and H. Hackstein. 2014. Identification of novel dendritic cell subset markers in human blood. Biochem. Biophys. Res. Commun. 443: 453-457.
34. Schooneman, F. 2003. Extracorporeal photopheresis technical aspects. Transfus. Apheresis Sci. 28: 51-61.
35. Jacob, M. C., O. Manches, P. Drillat, M. J. Richard, J. Plumas, L. Chaperot, H. Hegelhofer, F. Garban, R. Gressin, M. Favrot, et al. 2003. Quality control for the validation of extracorporeal photopheresis process using the Vilbert-Lourmat UV-A irradiation's system. Transfus. Apheresis Sci. 28: 63-70.
36. Garlanda, C., C. A. Dinarello, and A. Mantovani. 2013. The interleukin-1 family: back to the future. Immunity 39: 1003-1018.
37. Holtick, U., S. R. Marshall, X.-N. Wang, C. M. Hilkens, and A. M. Dickinson. 2008. Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocyte-derived dendritic cells. Transplantation 85: 757-766.
38. Bredberg, A., S. Jonsson, A. Lindblom, and P. Björk. 2007. Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis. Photodermatol. Photoimmunol. Photomed. 23: 113-119.
39. Spisek, R., Z. Gasova, and J. Bartunkova. 2006. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion 46: 55-65.
40. Kalinski, P., and H. Okada. 2010. Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors. Semin. Immunol. 22: 173-182.
41. Hackstein, H., and A. W. Thomson. 2004. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4: 24-34.
42. Jonuleit, H., U. Kühn, G. Müller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, and A. H. Enk. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serumfree conditions. Eur. J. Immunol. 27: 3135-3142.
43. Kalinski, P. 2009. Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4. Curr. Opin. Investig. Drugs 10: 526-535.
44. Antonopoulos, C., C. El Sanadi, W. J. Kaiser, E. S. Mocarski, and G. R. Dubyak. 2013. Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1b via caspase-8 in dendritic cells. J. Immunol. 191: 4789-4803.
45. Gringhuis, S. I., T. M. Kaptein, B. A. Wevers, B. Theelen, M. van der Vlist, T. Boekhout, and T. B. Geijtenbeek. 2012. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1b via a noncanonical caspase-8 inflammasome. Nat. Immunol. 13: 246-254.
46. Cauwels, A., E. Rogge, B. Vandendriessche, S. Shiva, and P. Brouckaert. 2014. Extracellular ATP drives systemic inflammation, tissue damage and mortality. Cell Death Dis. 5: e1102.
47. Koenen, H. J., R. L. Smeets, P. M. Vink, E. van Rijssen, A. M. H. Boots, and I. Joosten. 2008. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112: 2340-2352.
48. Mitchell, P. J., B. Afzali, H. Fazekasova, D. Chen, N. Ali, N. Powell, G. M. Lord, R. I. Lechler, and G. Lombardi. 2012. Helicobacter pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin-1b production by dendritic cells. Clin. Exp. Immunol. 170: 300-309.
49. Di Renzo, M., P. Rubegni, A. L. Pasqui, G. Pompella, G. De Aloe, P. Sbano, A. Cuccia, C. Castagnini, A. Auteri, F. Laghi Pasini, and M. Fimiani. 2005. Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease. Br. J. Dermatol. 153: 59-65.
50. Di Renzo, M., P. Sbano, G. De Aloe, A. L. Pasqui, P. Rubegni, A. Ghezzi, A. Auteri, and M. Fimiani. 2008. Extracorporeal photopheresis affects costimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients. Clin. Exp. Immunol. 151: 407-413.
51. Florek, M., E. I. Sega, D. B. Leveson-Gower, J. Baker, A. M. Müller, D. Schneidawind, E. Meyer, and R. S. Negrin. 2014. Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models. Blood 124: 1832-1842.
52. Schmitt, S., T. S. Johnson, S. Karakhanova, H. Näher, K. Mahnke, and A. H. Enk. 2009. Extracorporeal photophoresis augments function of CD4+ CD25+FoxP3+ regulatory T cells by triggering adenosine production. Transplantation 88: 411-416.